Zosano Pharma Announces the Appointment of Dushyant Pathak, Ph.D., as Senior Vice President of Business Development
18 sept. 2019 08h30 HE
|
Zosano Pharma Corporation
FREMONT, Calif., Sept. 18, 2019 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced the appointment of Dushyant Pathak, Ph.D., as...
Zosano Pharma Announces the Presentation of Multiple Positive Datasets from the Qtrypta™ Long-Term Safety Study at the Congress of the International Headache Society
09 sept. 2019 08h30 HE
|
Zosano Pharma Corporation
- Repeated Dosing of Qtrypta Over the Course of One Year Reaffirms Qtrypta is Effective and Well-Tolerated as an Acute Treatment for Migraine - - Efficacy and Safety Profile Consistent in Sub...
Zosano Pharma to Present at the H.C. Wainwright Annual Global Investment Conference
03 sept. 2019 09h00 HE
|
Zosano Pharma Corporation
FREMONT, Calif., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that its chairman, president and chief...
Zosano Pharma Announces Upcoming Oral and Poster Presentations at the Congress of the International Headache Society
23 août 2019 09h00 HE
|
Zosano Pharma Corporation
Oral presentation of the safety and efficacy of QtryptaTM in a long-term safety study for the acute treatment of migraine.Poster on the results of patients’ freedom from pain and most bothersome...
Zosano Pharma Reports Second Quarter 2019 Financial Results and Provides Corporate Update
14 août 2019 16h05 HE
|
Zosano Pharma Corporation
FREMONT, Calif., Aug. 14, 2019 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced financial results for the second quarter ended...
Zosano Pharma Files IND to Initiate a Phase 2/3 Clinical Study in Cluster Headache
14 août 2019 09h00 HE
|
Zosano Pharma Corporation
FREMONT, Calif., Aug. 14, 2019 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that the Company has submitted an...
Zosano Pharma to Host Conference Call on Second Quarter 2019 Financial Results and Provide Operational Update
07 août 2019 16h05 HE
|
Zosano Pharma Corporation
FREMONT, Calif., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that it will host a conference call and...
Zosano Pharma Presents Migraine-ACT Scores for Qtrypta™ at the American Headache Society (AHS) Annual Scientific Meeting
15 juil. 2019 06h00 HE
|
Zosano Pharma Corporation
FREMONT, Calif., July 15, 2019 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced the presentation of Migraine-ACT scores for...
Zosano Pharma Announces Keynote Speech at the Pharmaceutics & Advanced Drug Delivery Systems Conference
03 juil. 2019 08h30 HE
|
Zosano Pharma Corporation
FREMONT, Calif., July 03, 2019 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that Hayley Lewis, senior vice president of...
Zosano Pharma Announces Upcoming Presentation at American Headache Society Annual Meeting
01 juil. 2019 16h05 HE
|
Zosano Pharma Corporation
FREMONT, Calif., July 01, 2019 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that a poster and e-poster describing...